BMO Capital Downgrades Vitae Pharmaceuticals (VTAE) to Market Perform

September 15, 2016 7:10 AM EDT
Get Alerts VTAE Hot Sheet
Price: $21.00 +0.05%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 26 | Down: 29 | New: 38
Trade VTAE Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

BMO Capital downgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Outperform to Market Perform with a price target of $21.00 (from $17.00).

For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.

Shares of Vitae Pharmaceuticals closed at $20.85 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

BMO Capital

Add Your Comment